P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,334.05
173.15 (3.36%)
BSENSE

May 06

BSE+NSE Vol: 21.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Dec'18
Dec'17
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2024 is -6.37% vs 10.34% in Jun 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Jun 2024 is -12.42% vs 19.19% in Jun 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2024 is -5.75% vs 21.29% in Jun 2023

stock-summary

Interest

YoY Growth in year ended Jun 2024 is -6.49% vs 83.33% in Jun 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Jun 2024 has improved from Jun 2023

Compare Annual Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,151.26
1,174.37
-23.11
-1.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,151.26
1,174.37
-23.11
-1.97%
Raw Material Cost
290.23
537.18
-246.95
-45.97%
Purchase of Finished goods
39.46
102.06
-62.60
-61.34%
(Increase) / Decrease In Stocks
0.87
0.70
0.17
24.29%
Employee Cost
215.16
101.68
113.48
111.61%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
299.54
224.66
74.88
33.33%
Total Expenditure (Excl Depreciation)
845.26
966.28
-121.02
-12.52%
Operating Profit (PBDIT) excl Other Income
306.00
208.09
97.91
47.05%
Other Income
15.63
65.79
-50.16
-76.24%
Operating Profit (PBDIT)
321.63
273.88
47.75
17.43%
Interest
0.72
1.17
-0.45
-38.46%
Exceptional Items
-20.19
0.00
-20.19
Gross Profit (PBDT)
300.72
272.71
28.01
10.27%
Depreciation
27.40
29.45
-2.05
-6.96%
Profit Before Tax
273.32
243.26
30.06
12.36%
Tax
72.34
54.99
17.35
31.55%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
200.98
188.27
12.71
6.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
200.98
188.27
12.71
6.75%
Equity Capital
16.60
45.32
-28.72
-63.37%
Face Value
10.00
1.00
0.00
Reserves
521.64
1,338.17
-816.53
-61.02%
Earnings per share (EPS)
121.07
4.15
116.92
2,817.35%
Diluted Earnings per share
121.07
4.15
116.92
2,817.35%
Operating Profit Margin (Excl OI)
26.58%
17.72%
0.00
8.86%
Gross Profit Margin
26.12%
23.22%
0.00
2.90%
PAT Margin
17.46%
16.03%
0.00
1.43%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,151.26 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -6.37% vs 10.34% in Jun 2023

Annual - Standalone Net Profit
Standalone Net Profit 200.98 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -12.42% vs 19.19% in Jun 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 306.00 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -5.75% vs 21.29% in Jun 2023

Annual - Interest
Interest 0.72 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -6.49% vs 83.33% in Jun 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.58%
in Jun 2024

Figures in %
stock-summary

YoY Growth in year ended Jun 2024 has improved from Jun 2023